Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Retained Earnings (2016 - 2026)

Gyre Therapeutics has reported Retained Earnings over the past 16 years, most recently at -$68.4 million for Q4 2025.

  • Quarterly Retained Earnings fell 2533.81% to -$68.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$68.4 million through Dec 2025, down 2533.81% year-over-year, with the annual reading at -$68.4 million for FY2025, 2533.81% down from the prior year.
  • Retained Earnings was -$68.4 million for Q4 2025 at Gyre Therapeutics, down from -$1.7 million in the prior quarter.
  • Over five years, Retained Earnings peaked at -$392000.0 in Q4 2022 and troughed at -$417.2 million in Q1 2022.
  • The 5-year median for Retained Earnings is -$207.6 million (2021), against an average of -$215.6 million.
  • Year-over-year, Retained Earnings surged 99.9% in 2022 and then plummeted 2533.81% in 2025.
  • A 5-year view of Retained Earnings shows it stood at -$402.7 million in 2021, then skyrocketed by 99.9% to -$392000.0 in 2022, then crashed by 319.39% to -$1.6 million in 2023, then crashed by 57.97% to -$2.6 million in 2024, then plummeted by 2533.81% to -$68.4 million in 2025.
  • Per Business Quant, the three most recent readings for GYRE's Retained Earnings are -$68.4 million (Q4 2025), -$1.7 million (Q3 2025), and -$70.3 million (Q2 2025).